.OS Therapies are going to detail on the NYSE American inventory substitution today by means of a $6...
.ALX Oncology's phase 2 gastric cancer cells reaction price has actually diminished. After observing...
.One More of Ionis Pharmaceuticals' key midphase readouts has disappointed assumptions, cuing the bi...
.While Biogen's pharma peers are hunting for late-stage resources along with little bit of threat, C...
.Instil Biography has been a biotech trying to find a pipe after it scrapped its own lead assets ove...
.Biogen has actually restored rights to an early Alzheimer's health condition course to Denali Thera...
.Accept to recently's Chutes & Ladders, our roundup of considerable leadership hirings, firings a...
.Tip's attempt to alleviate an unusual hereditary health condition has struck yet another drawback. ...
.Vir Biotechnology's second-quarter revenues document wasn't short of big headlines. The business we...
.Galapagos has stopped briefly enrollment in a test of a BCMA-directed CAR-T tissue treatment, pushi...